Fusion Pharmaceuticals Inc, a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced the presentation of preclinical data for FPI-2068, a...
Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced the presentation of imaging data from the "cold...
Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, announced nomination of the first targeted alpha therapy (TAT)...
